Release Date: 30/11/22 20:28 Summary: Notification of cessation of securities - BRB Price Sensitive: No Download Document 22.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%